ThromboGenics completes private placement

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Date completed: 11/17/09 Type: Private placement Raised: €42.3 million ($63.3 million) Shares: 2.6 million Price...